Background: Pityriasis versicolor (tinea versicolor) is a common skin disorder due to Malassezia usually affecting adolescents and young adults, more frequently in the tropics. Facial involvement, isolated or not, is not frequent in white adults. Objective: Here, we report a possible atypical hyperkeratotic form of dermatosis of the face, in two young immunocompetent Caucasian patients, particularly recalcitrant to therapy. Results: Skin scrapings grew yeasts belonging to the genus Malassezia, including both M. globosa and M. sympodialis. This unusual variant needs long-term therapy with systemic and topical imidazoles together with facial cleansing. Conclusion: We propose the name hyperkeratotic head and neck Malassezia dermatosis for this distinctive clinical entity. This variant of pityriasis versicolor should be considered in the differential diagnosis of seborrheic dermatitis and dermatitis neglecta.

1.
Roberts SO: Pityriasis versicolor: a clinical and mycological investigation. Br J Dermatol 1969;81:315–326.
2.
Gueho E, Boekhout T, Ashbee HR, Guillot J, Van Belkum A, Faergemann J: The role of Malassezia species in the ecology of human skin and as pathogens. Med Mycol 1998;36(suppl 1):220–229.
3.
Gupta AK, Batra R, Bluhm R, Boekhout T, Dawson TL: Skin diseases associated with Malassezia species. J Am Acad Dermatol 2004;51:785–798.
4.
Sugita T, Takashima M, Kodama M, Tsuboi R, Nishikawa A: Description of a new yeast species, Malassezia japonica, and its detection in patients with atopic dermatitis and healthy subjects. J Clin Microbiol 2003;41:4695–4699.
5.
Hirai A, Kano R, Makimura K, Duarte ER, Hamadan JS, Lachance MA, Yamagushi H, Hasegawa A: Malassezia nana sp. nov., a novel lipid-dependent yeast species isolated from animals. Int J Syst Evol Microbiol 2004;54:623–627.
6.
Sugita T, Tajima M, Takashima M, Amaya M, Saito M, Tsuboi R, Nishikawa A: A new yeast, Malassezia yamatoensis, isolated from a patient with seborrheic dermatitis, and its distribution in patients and healthy subjects. Microbiol Immunol 2004;48:579–583.
7.
Cabanes FJ, Hernandez JJ, Castella G: Molecular analysis of Malassezia sympodialis-related strains from domestic animals. J Clin Microbiol 2005;43:277–283.
8.
Crespo Erchiga V, Ojeda Martos A, Vera Casano A, Crespo Erchiga A, Sanchez Fajardo F: Malassezia globosa as the causative agent of pityriasis versicolor. Br J Dermatol 2000;143:799–803.
9.
Nakabayashi A, Sei Y, Guillot J: Identification of Malassezia species isolated from patients with seborrhoeic dermatitis, atopic dermatitis, pityriasis versicolor and normal subjects. Med Mycol 2000;38:337–341.
10.
Gupta AK, Kohli Y, Faergemann J, Summerbell RC: Epidemiology of Malassezia yeasts associated with pityriasis versicolor in Ontario, Canada. Med Mycol 2001;39:199–206.
11.
Aspiroz C, Ara M, Varea M, Rezusta A, Rubio C: Isolation of Malassezia globosa and M. sympodialis from patients with pityriasis versicolor in Spain. Mycopathologia 2002;154:111–117.
12.
Perez Blanco M, Urbina de Guanipa O, Fernandez Zeppenfeldt G, Richard de Yegres N: Influencia de la temperatura y la humedad en la frequencia de pityriasis versicolor. Estudio epidemiologico en el Estado Falcon, Venezuela. Invest Clin 1990;31:121–128.
13.
Pontasch MJ, Kyanko ME, Brodell RT: Tinea versicolor of the face in black children in a temperate region. Cutis 1989;43:81–84.
14.
Bouassida S, Boudaya S, Ghorbel R, Meziou TJ, Marrekchi S, Turki H, Zahaf A: Pityriasis versicolor de l’enfant: étude retrospective de 164 cas. Ann Dermatol Venereol 1998;125:581–584.
15.
Bouassida S, Khemakhem M, Turki H, Boudaya S, Ayadi A, Zahaf A: Pityriasis versicolor de l’adulte: localisation particulière. Ann Dermatol Venereol 2002;129:904–905.
16.
Terragni L, Lasagni A, Oriani A: Pityriasis versicolor of the face. Mycoses 1991;34:345–347.
17.
Van Cutsem J, Van Gerven F, Cauwenbergh G, Odds F, Janssen PA: The antiinflammatory effects of ketoconazole. A comparative study with hydrocortisone acetate in a model using living and killed Staphylococcus aureus on the skin of guinea pigs. J Am Acad Dermatol 1991;25:257–261.
18.
Van den Bossche H, Willemsens G, Janssen PA: Cytochrome-P-450-dependent metabolism of retinoic acid in rat skin microsomes: inhibition by ketoconazole. Skin Pharmacol 1988;1:176–185.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.